Earnings Conference Call to be held on May 2, 2007 at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong)
SHENYANG, China, April 27 /Xinhua-PRNewswire/ -- 3SBio Inc.
(Nasdaq: SSRX), a leading China based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the 2007 first quarter ended March 31, 2007 after the US market closes on Tuesday, May 1, 2007.
The earnings release will be available on the investor relations page of its website at www.3sbio.com.
Following the earnings announcement, 3SBio senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on Wednesday, May 2, 2007 to discuss its 2007 first quarter financial results and recent business activity. The conference call may be accessed by calling (US) +1 480 629 9562 / (UK) +44 (0)20 8515 2301 / (HK) +852 3009 5027. A telephone replay will be available shortly after the call until May 16, 2007 at (US) +1 303 590 3030/ (UK) +44 (0)20 7154 2833, Passcode: 3729376; and (HK) +852 2287 4304, Passcode: 088110#.
A live webcast of the conference call and replay will be available on the investor relations page of 3SBio's website at www.3sbio.com.
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at www.3sbio.com.
Investor Contact:
Clara Mak, CFO
3SBio Inc.
+86 24 2581 1820
Investor Relations(HK):
Ruby Yim
Taylor Rafferty
+852 3196 3712
Investor Relations(US):
Mahmoud Siddig
Taylor Rafferty
+1 (212)889-4350
Media Contact:
John Dooley
Taylor Rafferty
+1 (212)889-4350
